Stimcell Energetics (STME) Assets Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 101.76% |
| Nov 30, 2025 | 36.51% |
| Aug 31, 2025 | -26.83% |
| May 31, 2025 | -53.99% |
| Feb 28, 2025 | -79.11% |
| Nov 30, 2024 | 67.57% |
| Aug 31, 2024 | -64.06% |
| May 31, 2024 | -55.34% |
| Feb 29, 2024 | 489.51% |
| Nov 30, 2023 | -4.74% |
| Aug 31, 2023 | 118.11% |
| May 31, 2023 | 149.78% |
| Feb 28, 2023 | -74.69% |
| Nov 30, 2022 | -66.90% |
| Aug 31, 2022 | -71.96% |
| May 31, 2022 | -20.86% |
| Feb 28, 2022 | -45.12% |
| Nov 30, 2021 | -25.73% |
| Aug 31, 2021 | -57.29% |
| May 31, 2021 | -67.18% |
| Feb 28, 2021 | -55.45% |
| Nov 30, 2020 | -75.75% |
| Aug 31, 2020 | -47.02% |
| May 31, 2020 | -16.46% |
| Feb 29, 2020 | 1.18% |
| Nov 30, 2019 | 323.53% |
| Aug 31, 2019 | 766.52% |
| May 31, 2019 | 321.00% |
| Feb 28, 2019 | 36.43% |
| Nov 30, 2018 | -74.72% |
| Aug 31, 2018 | -90.24% |
| May 31, 2018 | -84.59% |
| Feb 28, 2018 | -51.44% |
| May 31, 2017 | 9.22% |
| May 31, 2014 | -89.06% |
| May 31, 2013 | -53.51% |
| Feb 28, 2013 | -58.09% |
| Nov 30, 2012 | 111,135.29% |
| May 31, 2012 | 138,811.76% |